164 related articles for article (PubMed ID: 10656728)
1. Cd44: a marker of squamous differentiation in adenosquamous neoplasms.
Ylagan LR; Scholes J; Demopoulos R
Arch Pathol Lab Med; 2000 Feb; 124(2):212-5. PubMed ID: 10656728
[TBL] [Abstract][Full Text] [Related]
2. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
[TBL] [Abstract][Full Text] [Related]
3. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
Turner JR; Odze RD; Crum CP; Resnick MB
Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of squamous epithelium in adenoacanthoma and adenosquamous carcinoma of the endometrium: immunoperoxidase analysis of involucrin and keratin localization.
Warhol MJ; Rice RH; Pinkus GS; Robboy SJ
Int J Gynecol Pathol; 1984; 3(1):82-91. PubMed ID: 6203856
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
[No Abstract] [Full Text] [Related]
7. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
Zaino RJ; Kurman RJ
Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
[TBL] [Abstract][Full Text] [Related]
8. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?
Park JJ; Sun D; Quade BJ; Flynn C; Sheets EE; Yang A; McKeon F; Crum CP
Am J Surg Pathol; 2000 Oct; 24(10):1414-9. PubMed ID: 11023104
[TBL] [Abstract][Full Text] [Related]
9. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycan expression in human lung-cancer cells.
Nackaerts K; Verbeken E; Deneffe G; Vanderschueren B; Demedts M; David G
Int J Cancer; 1997 Jun; 74(3):335-45. PubMed ID: 9221815
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression in intraoral salivary ductal papillomas and oral papillary squamous cell carcinoma.
Fitzpatrick SG; Montague LJ; Cohen DM; Bhattacharyya I
Head Neck Pathol; 2013 Jun; 7(2):122-8. PubMed ID: 23143465
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
14. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
15. CD44 is a marker of endocervical neoplasia.
Ibrahim EM; Blackett AD; Tidy JA; Wells M
Int J Gynecol Pathol; 1999 Apr; 18(2):101-8. PubMed ID: 10202665
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract][Full Text] [Related]
18. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma.
Ingle R; Jennings TA; Goodman ML; Pilch BZ; Bergman S; Ross JS
Am J Clin Pathol; 1998 Mar; 109(3):309-14. PubMed ID: 9495203
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cytokeratin expression in primary and metastatic carcinomas. Diagnostic application in surgical pathology.
Shah KD; Tabibzadeh SS; Gerber MA
Am J Clin Pathol; 1987 Jun; 87(6):708-15. PubMed ID: 2438926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]